High rates of severe disease and death due to SARS-CoV-2 infection in rheumatic disease patients treated with rituximab: a descriptive study

  1. Loarce-Martos, J.
  2. García-Fernández, A.
  3. López-Gutiérrez, F.
  4. García-García, V.
  5. Calvo-Sanz, L.
  6. del Bosque-Granero, I.
  7. Terán-Tinedo, M.A.
  8. Boteanu, A.
  9. Bachiller-Corral, J.
  10. Vázquez-Díaz, M.
Aldizkaria:
Rheumatology International

ISSN: 1437-160X,  0172-8172

Argitalpen urtea: 2020

Alea: 40

Zenbakia: 12

Orrialdeak: 2015-2021

Mota: Artikulua

DOI: 10.1007/S00296-020-04699-X GOOGLE SCHOLAR lock_openSarbide irekia editor

Garapen Iraunkorreko Helburuak

Datuen iturria: Scopus